Publication | Closed Access
Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial
57
Citations
15
References
2019
Year
In this randomized controlled trial of treatment with Adalimumab in patients with refractory pouchitis, we were not able to identify any clinical benefit in the primary or secondary endpoints.
| Year | Citations | |
|---|---|---|
Page 1
Page 1